Cardiac amyloidosis is a condition that occurs when abnormal proteins called "amyloid" build up in your heart. These proteins can develop and grow in the heart tissue, increasing your risk for ...

The prognosis of patients with cardiac amyloidosis is affected by their cardiac condition, the extracardiac involvement and the modality of treatment of the underlying disease. Another predictor ...

Amyloid heart disease occurs when amyloid fibrils build up in the heart, making it more difficult for the heart to pump blood around the body. Eventually, this can lead to heart failure.

Several case reports and retrospective cohort studies have described a marginal benefit with the use of internal cardioverter defibrillators in patients with cardiac amyloidosis. Detection of ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Actor Chris Tucker, who portrays White in the “Air” film inspired by the Jordan brand, also donated to the new Providence ...

Michael Jordan donates $1 million to the Providence Heart Institute in Portland to establish the Howard White cardiac amyloidosis center.

To make a gift to support the Howard “H” White Center for Cardiac Amyloidosis, click here. This segment is sponsored by Providence Health and Services.

in a contemporary ATTR amyloidosis with cardiomyopathy patient population. The data demonstrated that rapid knockdown of TTR leads to an early impact on cardiac biomarkers and echocardiographic ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.